Showing results (941-950 of 2,413) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|September 29, 2015
The economic burden of chronic obstructive pulmonary disease from 2004 to 2013Jinhyun Kim, Tae Jin Lee, Sungjae Kim, et al.Journal of Medical Economics|October 28, 2014
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysisJohn M Kane, Cathy Zhao, Brian R Johnson, et al.Journal of Medical Economics|October 28, 2014
Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in CanadaC L Attard, A N Pepper, S T Brown, et al.Journal of Medical Economics|October 29, 2014
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and GermanyEvelyn Walter, Per OdinJournal of Medical Economics|August 27, 2014
Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial dataMin-Hua Jen, Hannah Kurth, Ike Iheanacho, et al.Journal of Medical Economics|December 20, 2014
An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United StatesAnita H Sung, Stephen W Marcella, Yang XieJournal of Medical Economics|December 20, 2014
Direct medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort studyPeter Sun, Zhimei Liu, Darcy Krueger, et al.Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.Journal of Medical Economics|November 26, 2014
A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UKIskandar Idris, Jason Gordon, Carl Tilling, et al.Journal of Medical Economics|January 17, 2020
Health technology assessment in Japan: a work in progressIsao Kamae, Rob Thwaites, Anna Hamada, et al.Pageof 242